Functional interplay between short antimicrobial peptides and model lipid membranes

Area of Science:

• Biochemistry
• Microbiology
• Drug Discovery

Background:

• Antimicrobial peptides (AMPs) are promising novel antibiotics with broad-spectrum activity and low cytotoxicity.
• The precise mechanism of AMP-induced bacterial membrane perturbation remains incompletely understood.
• RiLK1 and RiLK3 are AMPs with known affinity for bacterial membranes, but their action mechanism requires further elucidation.

Purpose of the Study:

• To investigate the membrane interaction and mechanism of action of AMPs RiLK1 and RiLK3.
• To evaluate the efficacy of RiLK1 and RiLK3 against bacterial membranes and antibiotic-resistant pathogens.

Main Methods:

• Fluorescence and quenching assays using acrylamide and lipophilic probes.
• Carboxyfluorescein leakage assays from bacterial liposomes.
• Dynamic Light Scattering (DLS) analysis.
• Minimum Inhibitory Concentration (MIC) determination against ESKAPE pathogens.

Main Results:

• RiLK1 and RiLK3 peptides localize at the interface of negatively charged bacterial membranes, potentially in a parallel orientation.
• Significant carboxyfluorescein leakage from bacterial liposomes indicates membrane permeabilization at high peptide concentrations.
• At concentrations near their MIC values, RiLK1 and RiLK3 exhibit cell-penetrating peptide (CPP)-like behavior.
• DLS provided further insights into the peptide-membrane interaction mechanisms.
• RiLK1 and RiLK3 demonstrated potent bacteriostatic efficacy at low micromolar concentrations against an antibiotic-resistant ESKAPE pathogen.

Conclusions:

• RiLK1 and RiLK3 effectively interact with and permeabilize bacterial membranes, leading to bacteriostatic effects.
• These peptides show significant potential as therapeutic agents against antibiotic-resistant infections.
• Further research into RiLK1 and RiLK3 could lead to the development of new antimicrobial strategies.